KEGG   DRUG: Ziltivekimab
Entry
D12807                      Drug                                   
Name
Ziltivekimab (USAN/INN)
Formula
C6468H9976N1716O2014S44
Exact mass
145319.8667
Mol weight
145409.64
Sequence
(Heavy chain)
EVQLVESGGG LVQPGGSLRL SCAASGFTIS SNYMIWVRQA PGKGLEWVSD LYYYAGDTYY
ADSVKGRFTM SRDISKNTVY LQMNSLRAED TAVYYCARWA DDHPPWIDLW GRGTLVTVSS
ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS
GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKRVEP KSCDKTHTCP PCPAPELLGG
PSVFLFPPKP KDTLYITREP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN
STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
QQGNVFSCSV MHEALHNHYT QKSLSLSPGK
(Light chain)
DIQMTQSPST LSASVGDRVT ITCRASQGIS SWLAWYQQKP GKAPKVLIYK ASTLESGVPS
RFSGSGSGTE FTLTISSLQP DDFATYYCQQ SWLGGSFGQG TKLEIKRTVA APSVFIFPPS
DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
(Disulfide birde: H22-H96, H147-H203, H223-L213, H229-H'229, H232-H'232, H264-H324, H370-H428, H'22-H'96, H'147-H'203, H'223-L'213, H'264-H'324, H'370-H'428, L23-L88, L133-L193, L'23-L'88, L'133-L'193)
  Type
Peptide
Class
Immunological agent
 DG02019  Interleukin inhibitor
Efficacy
Immunomodulator, Anti-IL-6 antibody
  Type
Monoclonal antibody
Comment
Reducing the risk of major adverse cardiovascular events in adults
Target
IL6 [HSA:3569] [KO:K05405]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  JAK-STAT signaling pathway
Brite
Drug groups [BR:br08330]
 Immunological agent
  DG02019  Interleukin inhibitor
   D12807  Ziltivekimab
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Interleukins
    IL6
     D12807  Ziltivekimab (USAN/INN)
Other DBs
CAS: 2226654-05-1
PubChem: 497621220
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system